Hay fever vaccine specialist Allergy Therapeutics (LON:AGY) has appointed Nick Wykeham as its new finance director.
Wykeham, 51, was group financial controller at Skypharma until August last year, with a stint at ICI business Quest prior to that.
Peter Jensen, Allergy’s chairman said Wykeham’s experience in life sciences was well suited to Allergy.
He replaces Ian Postlethwaite who resigned in March after 14 years with the company and taken up the post of chief financial officer at healthcare company investor NetScientific (LON:NSCI).